CFGS
MYGN icon

Concourse Financial Group Securities’s Myriad Genetics MYGN Stock Holding History

Concourse Financial Group Securities’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,240
Closed -$52.1K – 1335
2024
Q4 		$52.1K Sell
4,240
-321
-7% -$5.92K ﹤0.01% 1195
2024
Q3 		$125K Buy
4,561
+117
+3% +$3.17K 0.01% 881
2024
Q2 		$109K Buy
4,444
+30
+0.7% +$658 0.01% 910
2024
Q1 		$94.1K Sell
4,414
-64
-1% -$1.38K 0.01% 939
2023
Q4 		$85.7K Sell
4,478
-806
-15% -$13.9K 0.01% 945
2023
Q3 		$84.8K Sell
5,284
-110
-2% -$2.09K 0.01% 906
2023
Q2 		$125K Buy
5,394
+370
+7% +$8.07K 0.01% 796
2023
Q1 		$117K Sell
5,024
-410
-8% -$8.33K 0.01% 823
2022
Q4 		$78.8K Sell
5,434
-103
-2% -$1.92K 0.01% 912
2022
Q3 		$106K Sell
5,537
-204
-4% -$4.68K 0.01% 707
2022
Q2 		$104K Buy
5,741
+572
+11% +$11.9K 0.01% 797
2022
Q1 		$130K Sell
5,169
-43
-0.8% -$1.1K 0.01% 770
2021
Q4 		$144K Buy
5,212
+195
+4% +$5.65K 0.01% 847
2021
Q3 		$162K Sell
5,017
-235
-4% -$7.8K 0.01% 795
2021
Q2 		$161K Sell
5,252
-1,346
-20% -$38.9K 0.01% 784
2021
Q1 		$201K Sell
6,598
-524
-7% -$14.9K 0.01% 687
2020
Q4 		$141K Buy
7,122
+2,346
+49% +$37.9K 0.01% 755
2020
Q3 		$62K Buy
4,776
+287
+6% +$3.63K 0.01% 975
2020
Q2 		$51K Buy
4,489
+1,510
+51% +$21.4K 0.01% 984
2020
Q1 		$43K Buy
+2,979
New +$62.9K ﹤0.01% 964

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Concourse Financial Group Securities's MYGN Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Myriad Genetics (MYGN) in Q1 2025, closing a stake of 4,240 shares — an estimated $52.1K sold.

Concourse Financial Group Securities first reported a position in MYGN in Q1 2020 and held it in 20 quarters. The position peaked at $201K in Q1 2021. 228 funds tracked by Wall St. Rank hold MYGN as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Myriad Genetics position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 4,240 Myriad Genetics shares in Q1 2025, an estimated $52.1K.
  • Concourse Financial Group Securities first reported a position in Myriad Genetics in Q1 2020 and held it in 20 quarters.
  • Concourse Financial Group Securities's Myriad Genetics position peaked at $201K in Q1 2021.
  • 228 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.